Lakibol, Norailyn J.

HRN: 24-68-18  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/09/2024
CEFUROXIME 750MG (VIAL)
03/08/2024
03/15/2024
IV
130mg
Q8H
PCAP-C
Waiting Final Action 
03/09/2024
OXACILLIN 500MG (VIAL)
03/09/2024
03/15/2024
IV
295mg
Q6H
Impetigo
Waiting Final Action 
03/09/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/09/2024
03/15/2024
IV
55mg
Q24h
Sepsis
Waiting Final Action 
03/09/2024
CEFTAZIDIME 1GM (VIAL)
03/09/2024
03/16/2024
IV
190mg
Q8hours
T/c Sepsis; PCAP-D
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: